Raising estimates slightly & raising target $18 to $20 on continued strength in commodity pricing; next step for the stock will likely come from better execution, which takes longer. While we have had a persistently bullish outlook on memory since early this year, DRAM and NAND have both been slightly better than we expected qtd, and certainly better than the company's cautious outlook starting the quarter. Having said that, we were pounding the table on the stock at $10, and we aren't now - we think from here, the stock will outperform more gradually as the company shows benefit from DRAM and NAND cost reduction.
Pricing continues to be better, though we'd argue that's increasingly discounted by the stock at these levels. DRAM supply remains tight, and with DRAM spending down sharply we'd expect continued tightness, albeit with a seasonal overlay, through 2017. As we wrote about last week, we have see sharp DRAM migration during 3q from producer's balance sheets to customer's balance sheets - but lean producer balance sheets into 4q should create slower supply growth to mitigate the negative impact of customer prebuying. DRAM supply growth seems likely to be sub 20% next year, which should lead to continued tightness. NAND is also very tight heading into seasonal strength , but with potential step functions in supply as suppliers bring 3D online we'd expect more ups and downs through next year, but still with solid economics.
The key to Micron stock from here will be company-specific execution, where we look for 2 key transitions to gradually improve in costs, realized prices, & EPS. Micron has sharply underperformed peers on profitability the last 18 months, due to extended challenges integrating the manufacturing processes of the combined Elpida and Micron fabs (the 20 nm transition was the first process to roll out to all of the fabs globally), and limited cost benefits in the planar NAND business. While we don't expect Micron to regain the profit levels of Korean peers, we do expect to get closer in the coming quarters.
Execution in DRAM has already started to improve - we expect continued follow through. With 22% sequential bit growth last quarter, and higher bit growth this quarter, we are clearly seeing the inflection from the company's ramp of the 20 nm process. There is so much bit growth that we haven't seen benefits that we had hoped for from mix shift towards mobile, and growing bits by that much does create some strain, but in a fixed cost business reflects substantial cost reduction, and we expect substantial improvement in gross margins over the next couple of quarters. The key will be the fast migration to 18 nm that the company has been talking about, as a more mature integration of Elpida positions them to avoid the 20 nm delays. Fast migration to 18 nm should avoid repeating the relative underperformance that the company suffered in the 20 nm migration. We also note signs of better recent execution, with leadership on the GDDR5x graphics RAM standard and better mobile qualifications.
3D NAND transition moving in the right direction, though the pace of the transition has pressured earnings, and some risk remains. We see Micron moving from worst in class cost structure on planar to a middle of the pack cost structure in 3D, which should be a significant positive over time. But we had underestimated how difficult this transition has been, thus far. Taking planar capacity offline to convert to 3D is painful in a fixed cost business, and we estimate that margins should start to improve sharply in the November quarter. It's still not entirely without risk, as the pace of the 3D ramp is so steep that there could be qualification issues that impact pricing, as we saw when the company brought it's Singapore fab up on NAND a couple of years ago. But the potential delta here is substantial, particularly with a relatively quick and less capital intensive migration from 32 layer to 64 layer coming. One key aspect of this transition is that there is substantial negative impact to the May and August quarters from taking planar capacity offline for conversion to 3D - this is low hanging fruit for improvement once the new capacity comes back.
Details on our estimate changes, and new price target goes from $18 to $20 - Our estimate changes are relatively small; we see EPS above the guided range for the August quarter (management guided to a loss of $0.16 to $0.24, we see a loss of $0.13), and we see November quarter EPS at $0.08 vs. our prior $0.06. We'd emphasize that these are small changes, as we had already budgeted for healthy improvement in pricing and were already at the high end of company guidance for the current quarter. For our price target, we are raising our through-cycle EPS estimate from $1.65 to $1.85, based on continued softer DRAM capex - and we expect to be at this EPS run rate within 12 months. We see "through cycle" earnings at slightly above the midpoint of peak ($3.50
稍微提高估計及提高目標 18 美元到 20 美元繼續實力在商品定價;下一步的股票很可能會從更好的執行,需要更長時間。而今年年初以來,我們都有記憶體前景持續看好,DRAM 和 NAND 都略好于我們預期 qt 離散度,和當然要比公司的未來持謹慎態度開始的季度。有的說,我們被擂著桌子上 10 美元,股票和我們不是現在 — — 我們以為從這裡,股票表現將超越更逐漸所示公司效益從 DRAM 和 NAND 降低成本。定價仍然是更好,雖然我們認為這越來越多地打折,折扣率在這些級別股票。DRAM 供應仍然緊張,和 DRAM 開支下降大幅我們預料將會繼續密性,儘管與季節性的覆蓋,到 2017 年之間。如我們寫了關於上個星期,我們看到鋒利的 DRAM 遷移期間從生產者的資產負債表對客戶的資產負債表-3q 但成 4q 精益生產資產負債表應創建供應增長放緩,以減輕客戶 prebuying 的負面影響。DRAM 供應增長似乎可能是子 20%明年,應導致持續性。NAND 快閃記憶體也是很緊的標題為季節性的力量,但在供應的潛在階梯函數為供應商帶來 3D 線上預料將會更加起伏跌宕通過下一年,但仍然以扎實的經濟學。微米股票從這裡的關鍵將特定于公司的執行,我們在哪裡尋找 2 的關鍵性轉變,逐步改善成本,實現了的價格和 EPS。微米大幅業績欠佳對盈利能力的同齡人,過去 18 個月,由於集成組合爾必達和微米晶圓廠 (20 毫微米過渡是第一個進程全球範圍內推出的所有晶圓廠),製造流程的擴展挑戰和有限平面的 nand 快閃記憶體業務成本效益。雖然我們並不指望微米重拾韓國同行的利潤水準,我們期望在未來幾個季度中靠近。Execution in DRAM has already started to improve - we expect continued follow through. With 22% sequential bit growth last quarter, and higher bit growth this quarter, we are clearly seeing the inflection from the company's ramp of the 20 nm process. There is so much bit growth that we haven't seen benefits that we had hoped for from mix shift towards mobile, and growing bits by that much does create some strain, but in a fixed cost business reflects substantial cost reduction, and we expect substantial improvement in gross margins over the next couple of quarters. The key will be the fast migration to 18 nm that the company has been talking about, as a more mature integration of Elpida positions them to avoid the 20 nm delays. Fast migration to 18 nm should avoid repeating the relative underperformance that the company suffered in the 20 nm migration. We also note signs of better recent execution, with leadership on the GDDR5x graphics RAM standard and better mobile qualifications.3D NAND transition moving in the right direction, though the pace of the transition has pressured earnings, and some risk remains. We see Micron moving from worst in class cost structure on planar to a middle of the pack cost structure in 3D, which should be a significant positive over time. But we had underestimated how difficult this transition has been, thus far. Taking planar capacity offline to convert to 3D is painful in a fixed cost business, and we estimate that margins should start to improve sharply in the November quarter. It's still not entirely without risk, as the pace of the 3D ramp is so steep that there could be qualification issues that impact pricing, as we saw when the company brought it's Singapore fab up on NAND a couple of years ago. But the potential delta here is substantial, particularly with a relatively quick and less capital intensive migration from 32 layer to 64 layer coming. One key aspect of this transition is that there is substantial negative impact to the May and August quarters from taking planar capacity offline for conversion to 3D - this is low hanging fruit for improvement once the new capacity comes back.Details on our estimate changes, and new price target goes from $18 to $20 - Our estimate changes are relatively small; we see EPS above the guided range for the August quarter (management guided to a loss of $0.16 to $0.24, we see a loss of $0.13), and we see November quarter EPS at $0.08 vs. our prior $0.06. We'd emphasize that these are small changes, as we had already budgeted for healthy improvement in pricing and were already at the high end of company guidance for the current quarter. For our price target, we are raising our through-cycle EPS estimate from $1.65 to $1.85, based on continued softer DRAM capex - and we expect to be at this EPS run rate within 12 months. We see "through cycle" earnings at slightly above the midpoint of peak ($3.50
正在翻譯中..
![](//zhcntimg.ilovetranslation.com/pic/loading_3.gif?v=b9814dd30c1d7c59_8619)